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Monitoring of Tissue Oxygenation: 
an everyday Clinical Challenge
 
Zsolt Molnar* and Marton Nemeth
Department of Anaesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary
Purpose of review: The aim of this article is to study the overview of pathophysiology 
and clinical application of central venous oxygen saturation monitoring in critically ill 
patients and during the perioperative period.
Recent findings: There are several clinical studies and animal experiments evalu-
ating the effects of goal-directed hemodynamic stabilization on critically ill patients. 
Recent systematic reviews and meta-analyses found that advanced hemodynamic 
endpoints-targeted management has a positive effect on outcome in high-risk sur-
gical patients. As all interventions aim to improve tissue oxygenation, it is of utmost 
importance to monitor the balance between oxygen delivery and consumption. For 
this purpose, central venous blood gas analysis provides an easily available tool in 
the everyday clinical practice. The adequate interpretation of central venous oxygen 
saturation renders the need of careful evaluation of several physiological and patho-
physiological circumstances. When appropriately evaluated, central venous oxygen 
saturation can be a valuable component of a multimodal individualized approach, in 
which components of oxygen delivery are put in the context of the patients’ individual 
oxygen consumption. In addition to guide therapy, central venous oxygen saturation 
may also serve as an early warning sign of inadequate oxygen delivery, which would 
otherwise remain hidden from the attending physician.
Summary: With the incorporation of central venous oxygen saturation in the everyday 
clinical routine, treatment could be better tailored for the patients’ actual needs; hence, 
it may also improve outcome.
Keywords: venous oxygen saturation, central venous oxygen saturation, oxygen debt, hemodynamic monitoring, 
oxygen delivery, oxygen consumption, goal-directed therapy
iNTRODUCTiON
Interventions to improve oxygen delivery and decrease oxygen consumption are the cornerstone of 
resuscitation in the critically ill patients and during the perioperative period of high-risk patients. 
Early recognition of the patients at risks and the implementation of adequate monitoring-guided 
interventions can have a profound effect on outcome. On the contrary, delaying adequate interven-
tions will inevitably lead to hypoperfusion, tissue hypoxia, and multiple-organ failure affecting 
both outcome and wasting of resources and costs (1). Therefore, the use of appropriate indices, 
which are able to detect the imbalance between oxygen delivery (DO2) and consumption (VO2), 
is mandatory for adequate management (2). Conventional parameters such as heart rate, mean 
arterial blood pressure, mental status, and urine output are robust warning signs of inadequate 
tissue perfusion, but for fine tuning of therapy detailed hemodynamic monitoring is warranted 
(3). The recent FENICE (Fluid Challenges In Intensive Care) trial indicate that there is a consid-
erable gap between the accumulating knowledge about the benefits of advanced hemodynamic 
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monitoring based optimization and the actual clinical practice. 
In more than 2,000 patients, fluid challenges were evaluated. The 
main indicator of administering fluid boluses was hypotension 
in 57%, and in 43% of cases, no hemodynamic variable was used 
to predict fluid responsiveness (4). Detailed assessment of global 
hemodynamic indices such as cardiac output (CO) and derived 
variables and also the measures of oxygen delivery and uptake 
should be taken into account to provide appropriate therapy for 
these patients (5, 6). Furthermore, in addition to the optimiza-
tion of global hemodynamic parameters, indicators of tissue 
perfusion should also be monitored to verify the effectiveness 
of our interventions (7). To monitor changes in tissue oxygena-
tion, central or mixed venous blood gas measurements can give 
more detailed information, which should be incorporated into 
a multimodal approach that can lead to a better, individualized, 
patient-centered care. The goal of this review is to highlight the 
importance of central venous oxygen saturation in this multi-
modal, individualized hemodynamic management in the context 
of the pathophysiological background and the results of recent 
clinical and experimental studies.
PHYSiOLOGiCAL iSSUeS
Tissue oxygenation is the net product of oxygen delivery and 
oxygen consumption, which can be described by the following 
formulae (8):
 
DO = CO CaO
CaO = Hb 1.34 SaO +0.003 PaO
DO = CO Hb 1.34 S(
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If SaO2 is taken as 1, as under normal circumstances, the 
hemoglobin is almost fully saturated with oxygen, and the other 
hemodynamic variables are kept constant, then:
 O ER 1  ScvO .2 2» −  
DO2, oxygen delivery; CO, cardiac output; Hb, hemoglobin; 
SaO2, arterial oxygen saturation; PaO2, partial pressure of oxygen 
in the arterial blood; CaO2, arterial oxygen content; VO2, oxygen 
consumption; ScvO2, central venous oxygen saturation; CcvO2, 
central venous oxygen content; O2ER, oxygen extraction; PcvO2, 
central venous partial pressure of oxygen.
Taking a 75-kg healthy adult man when resting, the relation-
ship between DO2 and VO2 can be estimated as:
Oxygen delivery:
 
CO = 70ml 70/min ~ 5,000ml/min.
CaO = 150g/l 1.34ml  1.00 +(2
×
× ×( ) 0.003 100mmHg ~200ml/l.
DO ~ 1,000ml/min.
)
 2
×
 
Oxygen consumption:
 
CO = 70ml  70/min ~ 5,000ml/min.
CcvO = 150g/l 1.34 ml 0.75( )2
×
× × + 0.003 40mmHg ~ 150ml/l.
VO = 5l/min  200ml/l  150ml/l
( ) 
2
×
× ( )−  ~ 250 ml/min.  
Oxygen extraction:
 O ER: 250 ml/min/1,000 ml/min  100 = 25%.2 ×  
The main difference between the equations of DO2 and VO2 is 
the oxygen content (CaO2 versus CcvO2), especially the central 
venous oxygen saturation (ScvO2). Therefore, it can be useful to 
assess the imbalance between DO2 and VO2 in the critically ill.
When the arterial oxygen content (CaO2) and/or CO becomes 
impaired, DO2 decreases, which is often accompanied by a paral-
lel decrease in VO2. The most frequently occurring scenarios 
are represented in Figure  1. In the early phase of decreasing 
DO2, the circulation can compensate to some extent, and VO2 
remains stable. However, beyond a critical point, any further drop 
in DO2 will result in a decrease in VO2. From this point, VO2 
becomes dependent on DO2, and aerobic metabolism will have 
to be switched to anaerobic metabolism, leading to low ScvO2, 
hyperlactatemia, metabolic acidosis, and oxygen debt (9).
The principle task of early resuscitation is to regain balance 
by optimizing the VO2/DO2 ratio. However, it is also important 
to define the endpoints of resuscitation to avoid overresuscita-
tion. In the case of fluid resuscitation, for example, unneces-
sary administration of fluids will lead to hypervolemia, which 
increases morbidity and mortality to a similar extent to that of 
hypovolemia (10, 11). Unjustified blood transfusions also carry 
the risk of hypervolemia and transmission of infections (12) or 
allergic reactions (13). There is evidence that prolonged use of 
catecholamines is associated with poor outcome (14). Therefore, 
it is important to recognize the point when tissue perfusion has 
been normalized, oxygen debt has been resolved, and resuscita-
tion has been terminated.
iNDiviDUALiZeD GOAL-DiReCTeD 
HeMODYNAMiC THeRAPY
The multimodal concept in hemodynamic monitoring enables us 
to appreciate that each patient is different, hence the so-called 
normal values, which are more or less appropriate for a given 
population may be inadequate for the given patient. Therefore, 
this concept can be translated into the individualized or per-
sonalized use of target endpoints to avoid underresuscitation or 
overresuscitation.
PARAMeTeRS FOR ASSeSSMeNT OF 
TiSSUe MeTABOLiSM
Mixed venous and Central venous Oxygen 
Saturation
Mixed venous oxygen saturation (SvO2) measured in the pulmo-
nary artery via a pulmonary artery catheter, and its surrogate, 
FiGURe 1 | Oxygen delivery and consumption in critically ill patients. DO2, oxygen delivery; VO2, oxygen consumption; ScvO2, central venous oxygen saturation 
ratio. For details, see main text.
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central venous oxygen saturation (ScvO2) measured in the supe-
rior vena cava are the most commonly used parameters to assess 
global oxygen extraction (VO2/DO2). As central venous catheters 
are frequently applied in most critically ill patients, ScvO2 is more 
readily available compared to SvO2. Although the absolute values 
of ScvO2 are 5% higher than SvO2 on average, but changes usually 
occur in a parallel manner (15), therefore ScvO2 is regarded as a 
surrogate marker in the clinical setting (16, 17).
The main factors, which influence ScvO2, are hemoglobin, 
arterial oxygen saturation of hemoglobin, CO, and oxygen con-
sumption. There are multiple physiologic, pathophysiologic, and 
therapeutic factors that influence venous oxygen saturation such 
as anemia, hypovolemia, contractility, bleeding, sedation, fever, 
and pain (18).
ScvO2 in intensive Care Patients
During sepsis, organ dysfunction is most likely the result of inad-
equate tissue perfusion causing cellular hypoxia. Interventions 
improving the balance between DO2 and VO2 may prevent 
the development of tissue hypoperfusion, organ dysfunction 
syndrome, and thus improve the outcome of septic patients. In 
patients with early phase of severe sepsis, septic shock, early goal-
directed intervention guided by continuous monitoring of ScvO2, 
central venous pressure and mean arterial pressure (MAP), with 
target values of CVP 8 to 12  mmHg, MAP >  65  mmHg and 
ScvO2 > 70%, reduced mortality from 46.5 to 30.5% at the 28th 
day (19).
Although this study has been criticized for several reasons 
and these results could never be repeated, there is international 
consensus that that low ScvO2 values are very important warning 
signs of inadequate DO2 and can prognosticate complications 
and poor outcome. However, recent data suggest that high ScvO2 
values may also have adverse outcomes in septic patients (20). 
Due to deranged microcirculation when shunting is present on 
the level of capillaries, impaired oxygen utilization can lead to 
normal or supraphysiological ScvO2 values, which represent an 
inability of the cells to extract oxygen in sepsis (21). In patients 
with ScvO2 > 70% complementary blood gas parameters, such 
as elevated venous-to-arterial CO2 gap (dCO2) (>6  mmHg), 
increased or persistently elevated serum lactate levels could 
help the clinicians to identify tissue hypoxia. In a retrospective 
analysis, septic patients with physiological ScvO2 and abnormal 
dCO2 mortality was significantly higher as compared to patients 
with normal dCO2 values (22).
In patients treated on intensive care units, heart failure is often 
present resulting impaired CO, hence decreased oxygen delivery 
(23), and resulting oxygen extraction imbalance that could be 
detected by low ScvO2 (24). In a clinical study after myocardial 
infarction in patients with heart failure and cardiogenic shock, 
SvO2 was 43%, while in patients with heart failure without shock, 
it was 56% compared to patients without heart failure with an 
SvO2 of 70% (25). It may also be useful in patients with cardio-
genic shock requiring the support by intraaortic balloon counter 
pulsation. In a study during weaning period, intraaortic balloon 
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pump assist ratio was decreased from 1:1 to 1:3. In the weaning 
failure group, decreased support was accompanied by a drop in 
ScvO2, while it remained constant in the successful group (26). In 
patients with chronic heart failure, ScvO2 can be chronically low. 
However, during acute decompensation, major cardiac events 
were observed in 81% of patients with ScvO2 ≤ 60% at 24 h after 
ICU admission, while it was only 13% in patients with higher 
ScvO2 (27).
ScvO2 and Blood Transfusion
In addition to heart failure, anemia is another frequent cause 
of impaired DO2 in critically ill patients, and almost 40–45% 
of patients will receive blood transfusion during the treatment 
period (28). As large multicenter trials (TRICC and TRISS) sug-
gest that patients with hemoglobin levels above 10 mg/dl usually 
do not require transfusion, while red blood cell administration 
is usually beneficial if the hemoglobin level is below 7 mg/dl (29, 
30). Between these values, physicians have to make decisions 
according to clinical signs like mental status, tachycardia, tachyp-
nea, blood pressure, and diuresis. To be able to give additional 
objective data about oxygen debt of organs, ScvO2 may offer an 
easily obtainable tool to detect a low hemoglobin-related altered 
O2ER and hence may serve as a physiological trigger for blood 
transfusion (30). In human studies, both on volunteers and ret-
rospective data in critically ill patients suggest that lower levels of 
hemoglobin compared to that of recommended by international 
guidelines were well tolerated and did not produce hemody-
namic instability, and when oxygen imbalance occurred, it was 
accompanied by a significant drop in SvO2 (30–32). In our recent 
animal experiment on isovolemic anemia, we have found that 
anemia-induced change in VO2/DO2 showed significant correla-
tion with changes of ScvO2 (33); hence, ScvO2 may be used as a 
“physiologic transfusion trigger” in otherwise hemodynamically 
stable patients.
ScvO2 and High-Risk Surgery
High-risk surgical patients are at an increased risk of developing 
imbalance between VO2 and DO2 in the perioperative period; 
therefore, monitoring ScvO2 may have a rationale during both 
the intraoperative and postoperative managements.
It has been shown that patients with low ScvO2 values preop-
eratively, intraoperatively, or postoperatively are at an increased 
risk for complications and poor prognosis (34). Therefore, it seems 
to be logical to maintain ScvO2 in normal range during the perio-
perative care. We reported in a small, single-center prospective 
randomized study about continuously measured ScvO2-assisted 
intraoperative hemodynamic optimization (CeVOX Maquet® 
Munich Germany) during major abdominal surgery. In the con-
ventional group, patients were treated according to mean arterial 
and central venous pressure, while in the ScvO2 group, addition-
ally venous oxygen saturation was also measured via fiberoptic 
catheter placed in the superior vena cava. ScvO2 monitorization 
resulted in more interventions, more fluid boluses and more blood 
transfusion compared to the conventional group. These interven-
tion resulted in better organ functions, less complication rate, 
and better 28  days of survival (35). These results are in accord 
with the results of an earlier single-center study, where ScvO2 
over 73% directed group had fewer postoperative complications 
and had shorter length of hospital stay compared to patients in 
whom hemodynamic stabilization was guided according to MAP 
and central venous pressure (36). However, it is important to 
considerate that in anesthetized, mechanically ventilated patients, 
“physiological” values of ScvO2 are 5–10% higher (i.e., 75–80%) 
because of the decreased oxygen extraction of the brain. Second, 
when bleeding is present and blood loss is replaced by crystalloids, 
considerable hemodilution can take place. In our experimental 
stroke volume-guided hemorrhage and fluid resuscitation animal 
model, ScvO2 normalized at the end of resuscitation, but returned 
to a significantly lower level (with a mean of 5%) as the hemodilu-
tion caused significant drop in hemoglobin levels (37). In a clinical 
study performed on patients with esophagectomy, ScvO2 could 
indicate decreased DO2 caused by low hemoglobin levels; there-
fore, the authors suggest to use ScvO2 as complementary transfu-
sion trigger to hemoglobin in the perioperative period (32).
High-risk patient with major surgery benefits most from 
goal-directed therapy with significant reduction in mortality 
and morbidity compared to patients with low-risk interventions 
(38). ScvO2 is an important element of this complex periopera-
tive multimodal monitoring-based concept, including advanced 
hemodynamic monitoring and assessment of VO2/DO2, what we 
call the individualized, multimodal approach (39).
COMPLeMeNTARY BLOOD GAS 
PARAMeTeRS
venous-to-Arterial CO2 Gap (dCO2)
Mixed-, or central venous-to-arterial carbon dioxide gap is an 
easily attainable parameter when patients has arterial and central 
venous lines in  situ. The physiological value is ≤6 mmHg, and 
this holds true for both mixed- (Pv-aCO2) and central venous-to-
arterial (Pcv-aCO2) CO2 gap values. Therefore, the central venous 
Pcv-aCO2-gap can be useful surrogate of Pv-aCO2 in the everyday 
practice.
Increased CO2 gap of >40  mmHg was described 30  years 
ago during cardiac arrest in patients who were monitored with 
pulmonary artery catheters and also in an animal experiment 
on cardiopulmonary resuscitation (40). After these landmark 
studies, increased dCO2 was detected in several low-flow states 
(41–43). During anaerobic metabolism, increased production of 
hydrogen ions are buffered by bicarbonate presented in the cells, 
and this process will generate CO2 production (44). When the 
Fick principle is applied for carbon dioxide, there is an inverse 
relationship between the CO and dCO2 (45); in other words, 
increased levels of dCO2 should reflect low-flow states. Indeed, 
it has been shown that in sepsis, heart failure, and severe hypov-
olemia, its value can be elevated (46, 47).
In the perioperative setting, dCO2 also has a strong predictive 
value. Patients with high dCO2 had significantly higher mortal-
ity compared to patients with normal values (36.4 versus 4.5%) 
(48). High-risk surgical patients admitted to intensive care unit 
postoperatively with high dCO2 also developed more complica-
tions. The cutoff value was 5.8  mmHg (49), and in a different 
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clinical study, a dCO2 > 5 mmHg had 96% sensitivity to predict 
the occurrence of postoperative complications in patients with 
physiological (≥71%) ScvO2 (50). In critically ill patients, the 
dCO2 shows good inverse correlation with the CO (42), and it 
has also been shown to be a good predictor for bad outcome in 
patients with septic shock (41). In cases like septic shock, when 
due to microcirculatory or mitochondrial defects oxygen uptake 
is insufficient, ScvO2 can be supranormal. Previous studies have 
suggested that under such circumstances the increased value 
of dCO2 (>5  mmHg) and increased lactate level can help the 
physician in detecting inadequate flow to the tissues; hence, the 
complementary use of ScvO2 and dCO2 is recommended (50, 51).
CONCLUSiON
Early and adequate interventions to improve hemodynamics, oxy-
gen delivery, and reducing oxygen needs have a significant effect 
on outcome. Protocolized care with predefined values of certain 
physiological indices, such as blood pressure, CO, may benefit the 
majority of the population, but these values may be inadequate for 
the rest; hence, they will remain either underresuscitated or over-
resuscitated. Therefore, individualizing treatment should be desir-
able. For this purpose, additional physiological parameters like 
central venous oxygen saturation, lactate, and venous-to-arterial 
CO2 gap should be assessed together with other hemodynamic 
variables to get a detailed picture about the hemodynamic status 
of our patients. Putting the pieces of the puzzle together in context 
is what we define as multimodal, individualized hemodynamic 
support, in which ScvO2 has a pivotal role.
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